Ralph E. Parchment
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 34
- DNA Repair Mechanisms 21
- Oncology 84
- PARP inhibition in cancer therapy 29
- Cancer Treatment and Pharmacology 13
- Cancer Cells and Metastasis 12
- Co-authors
- James H. Doroshow (109 shared papers)Robert J. Kinders (75 shared papers)Joseph E. Tomaszewski (59 shared papers)G. Barry Pierce (11 shared papers)Andrea L. Lewellyn (3 shared papers)Shivaani Kummar (46 shared papers)Larry Rubinstein (37 shared papers)Jiuping Ji (15 shared papers)
- Journals
- Journal of Clinical Oncology (44 papers)Cancer Research (22 papers)Molecular Cancer Therapeutics (18 papers)Clinical Cancer Research (14 papers)Investigational New Drugs (9 papers)
- Partner nations
- United StatesMalaysiaSpain
In The Last Decade
Ralph E. Parchment
185 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 135
- Oncology 1.7k
- Cancer Research 709
- Statistics and Probability 273
- Molecular Biology 2.2k
- Toxicology 101
Countries citing papers authored by Ralph E. Parchment
This map shows the geographic impact of Ralph E. Parchment's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph E. Parchment with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph E. Parchment more than expected).
Fields of papers citing papers by Ralph E. Parchment
This network shows the impact of papers produced by Ralph E. Parchment. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph E. Parchment. The network helps show where Ralph E. Parchment may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralph E. Parchment, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 246 | |
| 2 | 2010 | 214 | |
| 3 | 2010 | 186 | |
| 4 | 1991 | 185 | |
| 5 | 2012 | 171 | |
| 6 | 2007 | 162 | |
| 7 | 2009 | 150 | |
| 8 | 2009 | 130 | |
| 9 | 2012 | 126 | |
| 10 | 1999 | 117 | |
| 11 | 2009 | 98 | |
| 12 | 2001 | 97 | |
| 13 | 1997 | 91 | |
| 14 | 1989 | 91 | |
| 15 | 1993 | 89 | |
| 16 | 2010 | 82 | |
| 17 | 2007 | 77 | |
| 18 | 2008 | 77 | |
| 19 | 2017 | 76 | |
| 20 | 2008 | 73 |
About Ralph E. Parchment
Ralph E. Parchment is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 191 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (34 papers), PARP inhibition in cancer therapy (29 papers), DNA Repair Mechanisms (21 papers), Cancer Genomics and Diagnostics (19 papers), Statistical Methods in Clinical Trials (14 papers), Cancer Treatment and Pharmacology (13 papers), Cancer Cells and Metastasis (12 papers) and Lung Cancer Treatments and Mutations (10 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (709 citations), Statistics and Probability (273 citations), Molecular Biology (2.2k citations) and Toxicology (101 citations). Ralph E. Parchment has collaborated with scholars based in United States, Malaysia and Spain. Frequent co-authors include James H. Doroshow, Robert J. Kinders, Joseph E. Tomaszewski, G. Barry Pierce, Andrea L. Lewellyn, Shivaani Kummar, Larry Rubinstein, Jiuping Ji, Melinda G. Hollingshead and Alice P. Chen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.